How Smoking Can Affect Your Eye Health
Today is the Great American Smokeout. Smoking remains the single largest cause of preventable disease and premature death in the United States. You probably know that smoking increases your risk of developing
read more
Celebrating Our Visionary Founders
Many of our “founding physicians” met for dinner this past weekend, including Albert Vaiser, MD, and William Hutton, MD, who along with William Snyder, MD, established Texas Retina Associates more than 50 years
read more
Celebrating Family Caregivers
November is National Family Caregivers Month. At Texas Retina Associates, we would like to recognize and thank all of the humble, unsung heroes who give of their own time and energy to
read more
Happy Veterans Day!
On behalf of everyone at Texas Retina Associates, we would like to extend our deepest gratitude for the sacrifices that our service members, both past and present, have made for our
read more
Dr. Abbey Taught a Course at the American Academy of Ophthalmology 2023 Annual Meeting
On November 6, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a continuing medical education (CME) course titled, “Secondary IOL Techniques for Retinal Specialists,” at AAO 2023, the annual meeting of the
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Three New Clinical Trials Available at Texas Retina
Medical researchers continue to make significant advances in the diagnosis and treatment of retinal conditions, and our physicians remain committed to participating in clinical trials that will improve care for our patients.
read more
Dr. Kothari to Speak at Retina World Congress Young Retina Connect Event
On October 29, 2023, Texas Retina Associates’ Nikisha Kothari, MD, will serve as one of seven panelists for Retina World Congress’ (RWC) “Young Retina Connect,” a virtual, interactive event involving retina specialists
read more
New Treatment for Wet AMD and Diabetic Eye Disease Reduces Treatment Burden for Patients by Extending Dosing Intervals
On August 18, 2023, the U.S. Food and Drug Administration (FDA) approved Eylea HD (aflibercept), a high-dose version of Eylea, for the treatment of several retinal conditions, including advanced neovascular age-related macular
read more
New Treatments Available for Geographic Atrophy
We know geographic atrophy (GA) can negatively impact patients’ quality of life and independence. While it still cannot be cured, Texas Retina is excited to finally have two new GA treatment options
read more